Status:
COMPLETED
Visual-OLfactory Training in Participants With COVID-19 Resultant Loss of Smell
Lead Sponsor:
Washington University School of Medicine
Conditions:
Anosmia
Covid19
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Olfactory dysfunction is a defining symptom of COVID-19 infection. As the number of total, confirmed COVID-19 cases approached 19 million in the United States, it is estimated that there will be 250,0...
Detailed Description
Over 200,000 people visit physicians yearly for taste and smell disorders and given the well-documented prevalence of olfactory dysfunction in COVID-19 infection, there is likely to be an increased ne...
Eligibility Criteria
Inclusion
- \- Subjective or clinically diagnosed olfactory dysfunction of 3 months duration or longer initially diagnosed within 2 weeks of a COVID-19 infection
Exclusion
- Diagnosed olfactory dysfunction due to head trauma
- Chronic rhinosinusitis
- Congenital olfactory dysfunction
- Nasal polyps
- Neurodegenerative disorders (for example, Alzheimer or Parkinson Disease)
- Pre-Assessment UPSIT score ≥34 for males and ≥35 for females
- Pregnant
- Inability to read, write, and understand English
- Inability to perform home olfactory training (for example, due to limited access to internet)
- Residence outside of the the United States of America
- Previously conducting smell training
Key Trial Info
Start Date :
January 11 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 11 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04710394
Start Date
January 11 2021
End Date
March 11 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine in Saint Louis
St Louis, Missouri, United States, 63108